Cholangiocarcinoma-Associated Ischemic Stroke: A Case Report and Literature Review

doi:10.3969/j.issn.1673-5765.2025.02.005

Chinese Journal of Stroke ›› 2025, Vol. 20 ›› Issue (2): 158-162.DOI: 10.3969/j.issn.1673-5765.2025.02.005

Previous Articles Next Articles

Cholangiocarcinoma-Associated Ischemic Stroke: A Case Report and Literature Review

WEI Jingwen, SONG Pingping, DING Yan, ZHANG Yusheng

Department of Neurology, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China

Received:2025-01-16 Online:2025-02-20 Published:2025-02-20
Contact: ZHANG Yusheng, E-mail: 757181750@qq.com

胆管细胞癌相关性缺血性卒中1例并文献复习

韦静雯，宋萍萍，丁燕，张玉生

广州 510630 暨南大学附属第一医院神经内科

通讯作者: 张玉生 757181750@qq.com
基金资助:
广东省自然科学基金面上项目（2020A1515011249）
中央高校基本科研业务费专项资金资助（21620406）
广州市科技计划项目（2023A03J0577；2023A04J1914）

Abstract

Abstract: Malignant tumors can significantly increase the risk of ischemic stroke, and ischemic stroke can exacerbate the condition of tumor patients, making it an important cause of non-neoplastic deaths. The pathogenesis of cancer-associated ischemic stroke (CAIS) is complex, with a generally poor prognosis. Therefore, early identification and comprehensive management of CAIS are of great significance for improving the prognosis of patients. This article reported the diagnosis and treatment process of a case of cholangiocarcinoma-associated ischemic stroke. Combined with literature review, the pathogenesis, clinical characteristics, treatment, and prognosis of CAIS were expounded, providing a reference for clinical practice.

Key words: Cancer-associated ischemic stroke; Cholangiocarcinoma; Trousseau’s syndrome; Hypercoagulabale state

摘要： 恶性肿瘤可明显增加缺血性卒中的发生风险，而缺血性卒中会加重肿瘤患者病情，是患者非肿瘤性死亡的重要原因。肿瘤相关性缺血性卒中（cancer-associated ischemic stroke，CAIS）发病机制复杂，预后差。早期识别和综合管理CAIS对改善患者预后有重要意义。本文报道1例胆管细胞癌相关性缺血性卒中病例的诊治过程，并结合文献复习，阐述CAIS的发病机制、临床特征、治疗与预后，为临床提供借鉴。

CLC Number:

WEI Jingwen, SONG Pingping, DING Yan, ZHANG Yusheng. Cholangiocarcinoma-Associated Ischemic Stroke: A Case Report and Literature Review[J]. Chinese Journal of Stroke, 2025, 20(2): 158-162.

韦静雯, 宋萍萍, 丁燕, 张玉生. 胆管细胞癌相关性缺血性卒中1例并文献复习[J]. 中国卒中杂志, 2025, 20(2): 158-162.

References

[1] DARDIOTIS E，ALOIZOU A M，MARKOULA S，et al. Cancer-associated stroke：pathophysiology，detection and management（review）[J]. Int J Oncol，2019，54（3）：779-796.
[2] 付睿. 肿瘤合并缺血性卒中的研究现状及展望[J]. 中国卒中杂志，2021，16（2）：119-122.
FU R. Current status and prospect in research of cancer-associated ischemic stroke[J]. Chin J Stroke，2021，16（2）：119-122.
[3] METHAROM P，FALASCA M，BERNDT M C. The history of armand Trousseau and cancer-associated thrombosis[J/OL]. Cancers（Basel），2019，11（2）：158[2025-01-02]. https://doi.org/10.3390/cancers11020158.
[4] SASAKI R，OHYA Y，HAYASHIDA S，et al. A case of Trousseau’s syndrome due to intrahepatic cholangiocarcinoma with an extremely high level of CA19-9[J/OL]. Surg Case Rep，2020，6（1）：75[2025-01-02]. https://doi.org/10.1186/s40792-020-00835-8.
[5] LI Y H，YU J F，ZHANG Y J，et al. Advances in targeted therapy of cholangiocarcinoma[J/OL]. Ann Med，2024，56（1）：2310196[2025-01-02]. https://doi.org/10.1080/07853890.2024.2310196.
[6] CHING C K. Trousseau’s syndrome in a patient with cholangiocarcinoma[J]. Am J Gastroenterol，1991，86（7）：928-929.
[7] KNEIHSL M，ENZINGER C，WÜNSCH G，et al. Poor short-term outcome in patients with ischaemic stroke and active cancer[J]. J Neurol，2016，263（1）：150-156.
[8] 姜季委，陈昱彤，彭乾，等. 癌症相关缺血性卒中研究进展[J]. 中国现代神经疾病杂志，2020，20（4）：359-365.
JIANG J W，CHEN Y T，HAN Q，et al. Research progress of cancer-associated ischemic stroke[J]. Chin J Contemp Neurol Neurosurg，2020，20（4）：359-365.
[9] NOUH A M，STAFF I，FINELLI P F. Three territory sign：an MRI marker of malignancy-related ischemic stroke（Trousseau syndrome）[J]. Neurol Clin Pract，2019，9（2）：124-128.
[10] FARGE D，FRERE C，CONNORS J M，et al. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer[J/OL]. Lancet Oncol，2019，20（10）：e566-e581[2025-01-02]. https://doi.org/10.1016/S1470-2045（19）30336-5.
[11] FALANGA A，AY C，DI NISIO M，et al. Venous thromboembolism in cancer patients：ESMO clinical practice guideline[J]. Ann Oncol，2023，34（5）：452-467.

Cholangiocarcinoma-Associated Ischemic Stroke: A Case Report and Literature Review

胆管细胞癌相关性缺血性卒中1例并文献复习

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 4

Recommended Articles

Metrics

[1]	XU Bingdong, LIN Yingze, WANG Shuhong, YANG Danping, XU Anding, ZHANG Yusheng. Focusing on the Identification and Management of Patients with Cancer-Associated Ischemic Stroke [J]. Chinese Journal of Stroke, 2025, 20(2): 131-136.
[2]	WANG Shuhong, XU Bingdong, LIN Yingze, YANG Danping, ZHANG Yusheng. Research Progress on the Pathogenesis of Cancer-Associated Ischemic Stroke [J]. Chinese Journal of Stroke, 2025, 20(2): 138-143.
[3]	ZHANG Hudie, SU Yingwen, LIN Jing, HONG Daojun. Analysis of Clinical and Imaging Features of Patients with Trousseau Syndrome Associated Cerebral Infarction [J]. Chinese Journal of Stroke, 2025, 20(2): 144-150.
[4]	LIN Yingze, WANG Shuhong, XU Bingdong, YANG Danping, GUAN Min, ZHANG Yusheng. Endovascular Treatment for Nasopharyngeal Carcinoma Associated Acute Ischemic Stroke Patients: A Report of Two Cases [J]. Chinese Journal of Stroke, 2025, 20(2): 151-157.